Skip to content

Association of Preoperative Hippocampal Glucose Metabolism With Postoperative Delirium in Older Diabetic Patients

Preoperative Hippocampal Glucose Metabolism Levels and the Risk of Postoperative Delirium in Older Patients With Type 2 Diabetes: A Prospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07369466
Enrollment
154
Registered
2026-01-27
Start date
2026-02-01
Completion date
2028-06-01
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium, Type 2 Diabetes

Keywords

Postoperative delirium, Type 2 Diabetes Mellitus, Positron-Emission Tomography, Hippocampus, Glucose metabolism

Brief summary

Objective: To investigate the association between preoperative hippocampal glucose metabolism levels and the risk of postoperative delirium (POD) in elderly patients with type 2 diabetes (T2DM), and to provide a prospective neuroimaging biomarker for identifying high-risk populations. Methods: This prospective cohort study plans to enroll 154 elderly T2DM patients scheduled for liver tumor resection at the First Medical Center of Chinese PLA General Hospital. Baseline cognitive function will be assessed using the Mini-Mental State Examination (MMSE) one day before surgery. Hippocampal glucose metabolism will be quantitatively evaluated by measuring the mean standardized uptake value (SUVmean) of bilateral hippocampi using ¹⁸F-FDG PET/CT. POD will be assessed twice daily from postoperative days 1 to 7 using the 3-Minute Diagnostic Interview for CAM (3D-CAM). The correlation between preoperative hippocampal SUVmean and POD incidence will be analyzed using univariate and multivariate logistic regression models. The predictive performance will be evaluated by constructing receiver operating characteristic (ROC) curves. Furthermore, the relationship between a peripheral insulin resistance marker (the triglyceride-glucose index, TyG index) and hippocampal metabolism levels will be analyzed. Significance: This study aims to determine whether impaired preoperative hippocampal metabolism serves as an independent risk factor for POD. The findings are expected to provide a prospective functional neuroimaging biomarker for the early warning of POD and offer a theoretical basis for developing precise prevention strategies targeting cerebral metabolic abnormalities. This will facilitate the application of neuroimaging techniques in the field of perioperative brain dysfunction monitoring.

Interventions

None listed

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with type 2 diabetes mellitus (T2DM). 2. Age ≥ 65 years. 3. Scheduled for elective liver tumor resection surgery with an expected operative duration \> 2 hours. 4. Underwent whole-body ¹⁸F-FDG PET/CT scan within 1 month prior to surgery.

Exclusion criteria

1. Patient declines to participate. 2. Inability to cooperate with cognitive assessments or a preoperative Mini-Mental State Examination (MMSE) score \< 23. 3. American Society of Anesthesiologists (ASA) physical status classification ≥ IV. 4. History of organic brain disorders, including stroke, traumatic brain injury, or intracranial tumors. 5. History of psychiatric disorders or current use of antipsychotic medications.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Postoperative Delirium (POD)From surgery completion to postoperative day 7Assessed by the 3-Minute Diagnostic Interview for CAM (3D-CAM), administered twice daily.

Secondary

MeasureTime frameDescription
Triglyceride-glucose (TyG) indexWithin 7 days before surgery (preoperative baseline)Calculated as Ln \[fasting triglycerides (mg/dL) × fasting glucose (mg/dL) / 2\].

Contacts

CONTACTWeidong Mi, Professor
wwdd1962@163.com86+13381082966
CONTACTDanyang Geng, Master
sphm123@126.com86+17367522284
STUDY_CHAIRWeidong Mi, Professor

The First Medical Center of Chinese PLA General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026